NF1 and neuroblastoma: Of interest, inhibition of the MEK kinase with a small-molecule inhibitor restores both ZNF423 expression and sensitivity to RA in NF1 knocked down cells, suggesting the therapeutic possibility for overcoming the RA resistance encountered in NB clinical practice.